Skip to content
Friday, July 1, 2022
Latest:
  • Copiktra (duvelisib) linked to Possible Increased Risk of Death and Serious Side Effects
  • TikTok Benadryl Challenge
  • The full list of hand sanitizers to avoid
  • FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
  • Is acetaminophen a carcinogen?

Faulty Drugs

Faulty Pharmaceutical Drugs Resources

  • Home
  • FDA Recalls
  • Drug Recalls
  • Current Lawsuits
  • Contact

Xeljanz

FDA Advisory Xeljanz 

Increased Risk of Blood Clots and Death in Xeljanz

July 26, 2019

FDA has approved new warnings about an increased risk of blood clots and of death with the 10 mg twice

Read more

Recent Posts

  • Copiktra (duvelisib) linked to Possible Increased Risk of Death and Serious Side Effects
  • TikTok Benadryl Challenge
  • The full list of hand sanitizers to avoid
  • FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
  • Is acetaminophen a carcinogen?

Categories

Useful Links

  • DailyMed – marketed drugs
  • FDA Drug Recalls
  • MedlinePlus Drugs Information
  • Pillbox – Pill identification
Copyright © 2022 Faulty Drugs. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.